Global (United States, European Union and China) Fludeoxyglucose (18F) Radionuclide Injection Market Research Report 2019-2025

Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.
United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.
ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
In 2019, the market size of Fludeoxyglucose (18F) Radionuclide Injection is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fludeoxyglucose (18F) Radionuclide Injection.

This report studies the global market size of Fludeoxyglucose (18F) Radionuclide Injection, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Fludeoxyglucose (18F) Radionuclide Injection production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Zevacor Pharma
Queen's PET Imaging
Triad Isotopes
NCM USA Bronx
Spectron MRC
Petnet Solutions
Shertech Laboratories
Precision Nuclear

Market Segment by Product Type
Cancer
Coronary Artery Disease
Others

Market Segment by Application
Hospitals
Clinics
Diagnostics Center

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Fludeoxyglucose (18F) Radionuclide Injection status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Fludeoxyglucose (18F) Radionuclide Injection manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Fludeoxyglucose (18F) Radionuclide Injection are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025